FDA Warns Two Contract Research Sites Over Protocol Violations
Executive Summary
Comprehensive Clinical Research has made several personnel changes in response to an FDA inspection that resulted in a June 5 warning letter
You may also be interested in...
Forest Aerobid Non-CFC Asthma Inhaler Launch Expected In Fall, C0O Says
Forest will launch its non-CFC version of the prescription asthma inhaler Aerobid (flunisolide) this fall, President and Chief Operating Officer Kenneth Goodman told analysts on a conference call Jan. 16.
Roche Tamiflu Labeled For Seasonal Prophylaxis With 42-Day Dosing Regimen
Roche/Gilead Tamiflu updated labeling includes data from a seasonal prophylaxis study in elderly nursing home residents who took oseltamivir for 42 days.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: